For the Inventor, By the Inventor

Enter assignee name

Albuquerque, NM, United States of America

Intellicyt Corporation

Calculating rank

USPTO Granted Patents = 18

% Expired Patents = 5.6

EPO Patents = 1

Trademarks = 6

Forward Citations = 92

Loading Chart...

Loading Chart...

23 inventors (with patents filed for the assignee):

Michael A Artinger (6 out of 14 patents)

Francis Kevin Kohlmeier (5 out of 12 patents)

Garrett S Wilson (4 out of 5 patents)

4. Kathy Lou Rowlen (4 out of 16 patents)

5. Tyler Gates (3 out of 11 patents)

6. Aaron Bryce Kennington (3 out of 7 patents)

7. Christopher Converse (3 out of 17 patents)

8. Michael W Olszowy (3 out of 13 patents)

9. Erica Dawson Tenent (3 out of 6 patents)

10. Braden Lindley Smith (3 out of 9 patents)

11. Jean-Luc Fraikin (2 out of 8 patents)

12. Andrew Smolak (2 out of 5 patents)

13. Joseph M Zock (2 out of 4 patents)

14. Linda Trinkle (2 out of 2 patents)

15. Bruce S Edwards (1 out of 22 patents)

18 patents: Sort by Forward Citations

1. 10184878 - Flow cytometer signal peak identification employing dynamic thresholding (2019-01-22),

2. 10161850 - Evaluating biological material for unassociated virus-size particles with influenza virus epitope (2018-12-25),

3. 10101262 - Evaluating biological material for unassociated virus-size particles with adeno-associated virus epitope (2018-10-16),

4. 10048191 - Methods and apparatus for real-time detection and clearing of a clog (2018-08-14),

5. 10031061 - Flow measurement and control for improved quantification of particles in flow cytometry (2018-07-24),

6. 9927346 - Flow cytometer system including flow cytometer, autosampler and system integration structure (2018-03-27),

7. 9903803 - Flow cytometer signal peak identification employing dynamic thresholding (2018-02-27),

8. 9897531 - Flow cytometry sample separation methods and apparatus (2018-02-20),

9. 9880085 - Flow cytometer system including flow cytometer, autosampler and system integration structure (2018-01-30),

10. 9850979 - Flow cytometer with optical system assembly having vibration isolation and shear protection structures (2017-12-26),

11. 9816912 - Evaluating biological material for unassociated virus-size particles having an adenovirus hexon protein epitope (2017-11-14),

12. 9797917 - Contact sensing probe and methods of use for microplate liquid sampling (2017-10-24),

13. D787701 - Flow cytometer system shelf unit (2017-05-23),

14. 9551644 - Methods and apparatus for real-time detection and clearing of a clog (2017-01-24),

15. D737703 - Particle analyzer (2015-09-01),

Company Overview

Intellicyt Corporation, based in Albuquerque, NM, specializes in advanced cell analysis and high-throughput screening technologies. The company focuses on developing innovative solutions that enhance research in the life sciences, particularly in immunology and oncology. By providing tools that streamline the process of cell-based assays, Intellicyt empowers researchers to gain deeper insights into cellular behavior and therapeutic responses, facilitating advancements in drug discovery and development.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

18 Patents

#32 in Albuquerque, NM

#43 in New Mexico

#17,980 in US

#34,263 in the World

Albuquerque, NM, United States of America

Intellicyt Corporation

Forward Citations = 92

23 inventors:

Michael A Artinger (6 out of 14 patents)

Francis Kevin Kohlmeier (5 out of 12 patents)

Garrett S Wilson (4 out of 5 patents)

4. Kathy Lou Rowlen (4 out of 16 patents)

5. Tyler Gates (3 out of 11 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Intellicyt Corporation. Retrieved from https://idiyas.com/company/intellicyt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…